STOK Financial Overview

Comprehensive financial analysis and stock performance data for STOK. This dashboard provides key metrics, financial ratios, and interactive charts to help you make informed investment decisions.

STOK

Stoke Therapeutics, Inc.

Healthcare
CEO: Ian F. Smith
IPO: 2019-06-19
128 employees
$13.53
0.37 (2.73%)

Market Cap

738.70M

Enterprise Value

466M

Revenue (TTM)

36.6M

Net Income

-88,981,000

P/E Ratio

15.57x

ROE

19.08%

Valuation Metrics
Market Cap
739M
Enterprise Value
466M
P/E Ratio
15.57x
P/S Ratio
3.87x
P/B Ratio
2.24x
EV/Sales
2.44x
EV/FCF
6.74x
Earnings Yield
6.42%
FCF Yield
9.37%
Price to Operating Cash Flow
11.26x
Gross Margin
98.26%
Margin Metrics
Operating Margin
20.03%
Net Margin
26.33%
Pretax Margin
27.00%
ROIC
10.23%
Dividends
Payout Ratio
0.00%
Dividend Yield
0.00%
Dividend per Share
$0.00
Return Metrics
ROE
19.08%
ROCE
10.56%
ROA
12.36%
PEG Ratio
0.10x
Payout Ratio
0.00%
Financial Health
Debt to Assets
0.58%
Net Debt/EBITDA
-6.85x
Growth Metrics
3Y Revenue Growth
0.00%
5Y Revenue Growth
0.00%
10Y Revenue Growth
0.00%
3Y Net Income Growth
8.73%
5Y Net Income Growth
-0.77%
10Y Net Income Growth
NaN%
3Y OCF Growth
3.76%
5Y OCF Growth
1.35%
10Y OCF Growth
NaN%

Stock Performance

Interactive stock chart with historical price data and comparison tools. Analyze price movements, volume trends, and compare with other stocks or indices.

STOK
AugSepOctNovNovDecJanFebMarAprMayJunJulAug5.48.411.416.4
STOK·Total: -4.52%·CAGR: -4.52%
Stoke Therapeutics, Inc. | Financial Overview | Monexa